Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This obesity-related form of hepatitis affects nearly one in four Americans and is on the rise across the country.
Many had misconceptions in a recent study.
The lawsuit claims the state “violates” standard medical care protocols by treating only people with advanced liver disease.
Some who resolved hep B have seen their infection reactivate while on hep C therapy.
Tips for getting and paying for Epclusa, the newest hepatitis C treatment approved by the FDA.
Massachusetts General Hospital recently became the first hospital in the United States to use it.
United HealthCare opened up access in order to settle a $300 million class action lawsuit brought against it by HCV-positive policyholders.
Despite the expansion of HIV treatment, rates of end-stage liver disease among those coinfected with hepatitis B or C remain unchanged.
The Albert and Mary Lasker Foundation’s annual awards honor several researchers whose work contributed to the development of HCV treatment.
Chronic fatigue among those with hep C may be partly a result of liver inflammation and scarring related to the infection.
Immunizations are safe and effective, so why doesn’t everyone protect their children?
While one in four people with hep C have advanced liver damage, many living with the virus aren’t even in regular medical care.
Editor-in-Chief of Hepatology, Medicine & Policy reflects on the need to bring health systems questions into the viral hepatitis discourse
In 2012, the AHSA hired a medical technician at the facility who had a long disciplinary record of drug use on the job.